TITLE

Aspirin Following Anticoagulation Therapy Prevents Recurrent VTE

AUTHOR(S)
KULKARNI, NITA SHRIKANT
PUB. DATE
June 2013
SOURCE
American Family Physician;6/1/2013, Vol. 87 Issue 11, p798
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article provides an answer to a question of whether aspirin prevents recurrent venous thromboembolism (VTE) in patients who have completed an initial course of anticoagulation therapy.
ACCESSION #
87646681

 

Related Articles

  • Aspirin did not reduce recurrence after a first-ever, unprovoked venous thromboembolism. DeLoughery, Thomas // Annals of Internal Medicine;3/19/2013, Vol. 158 Issue 6, pJC2 

    The article studies the effect of aspirin on recurrence of venous thromboembolism (VTE). It informs that 822 patients above 18 years of age who had deep venous thrombosis (DVT) or acute pulmonary embolism (PE) were diagnosed for aspirin. The result showed that adults who completed anticoagulant...

  • Understanding anticoagulation therapy for stroke prevention and atrial fibrillation. Schellack, Natalie; Esterhuizen, Heleen; Schellack, Gustav // South African Pharmaceutical Journal;2013, Vol. 80 Issue 7, p13 

    Atrial fibrillation (AF) is a common cardiac rhythm disorder and patients with this condition are at an increased risk of strokes and other thromboembolic events. Available treatment options for the prevention of strokes in patients with AF include warfarin, aspirin and the novel oral...

  • Can Aspirin Prevent Recurrence of Thromboembolism? Kuritzky, Louis // Internal Medicine Alert;7/15/2012, Vol. 34 Issue 13, p103 

    The article discusses a study which reports potential benefit of the drug Aspirin on prevention of thromboembolism that causes obstruction of blood vessels by formation of blood clots.

  • Prevention of Venous Thromboembolism after Arthroscopic: Knee Surgery in a Low-Risk Population with the Use of Aspirin A Randomized Trial. David Kaye, I.; Patel, Deepan N.; Strauss, Eric J.; Alaia, Michael J.; Garofolo, Garret; Martinez, Amaury; Jazrawi, Laith M. // Bulletin of the Hospital for Joint Diseases;2015, Vol. 73 Issue 4, p243 

    Introduction: Historically, venous thromboembolism (VTE) in the setting of elective knee arthroscopy has been considered rare. However, more recently, the rate of deep vein thrombosis (DVT) has been reported to be approximately 10%. With increasing recognition of the potential for the...

  • Aspirin Has a Protective Effect Against Adverse Outcomes in Patients with Nonvariceal Upper Gastrointestinal Bleeding. Wehbeh, Antonios; Tamim, Hani; Abu Daya, Hussein; Abou Mrad, Rachel; Badreddine, Rami; Eloubeidi, Mohamad; Rockey, Don; Barada, Kassem // Digestive Diseases & Sciences;Jul2015, Vol. 60 Issue 7, p2077 

    Objective: To determine the effect of aspirin and anticoagulants on clinical outcomes and cause of in-hospital death in patients with nonvariceal upper gastrointestinal bleeding (NVUGIB). Methods: Patients were identified from a tertiary center database that included all patients with UGIB....

  • To prevent thromboembolism, give oral anticoagulants for 6 months, not 6 weeks.  // Modern Medicine;Oct95, Vol. 63 Issue 10, p50 

    Presents an abstract of the article `A Comparison of Six Weeks With Six Months of Oral Anticoagulant Therapy After a First Episode of Venous Thromboembolism,' by S. Schulman, A.-S. Rhedin, P. Lindmarker, et al from the `New England Journal of Medicine' dated June 22, 1995.

  • Extending anticoagulant regimen helps prevent thromboembolisms.  // Formulary;Oct95, Vol. 30 Issue 10, p621 

    Presents an abstract of the medical study `A Comparison of Six Weeks With Six Months of Oral Anticoagulant Therapy After a First Episode of Venous Thromboembolism,' by S. Schulman, A-S Rhedin et al, published in the North England Journal of Medicine 1995.

  • Duration of anticoagulation for venous thromboembolism. Middeldorp, Saskia // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;6/11/2011, Vol. 342 Issue 7810, p1270 

    The article presents the author's views on the adverse impact of anticoagulant treatment. He states that venous thromboembolism often recur after anticoagulant treatment is stopped. He argues for how long patients with venous thromboembolism should be given anticoagulants. He asserts that the...

  • Warfasa: Aspirin associated with 40% reduced risk for unprovoked VTE recurrence. Becattini, C // Hem/Onc Today;12/25/2011, Vol. 12 Issue 24, p58 

    The article reports on the association between aspirin intake after anticoagulant therapy and 40 percent reduction of risk for unprovoked venous thromboembolism (VTE) recurrence, according to results of the Warfasa study at the Univeristy of Perugia in Italy.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics